跳至主要内容
临床试验/EUCTR2011-001386-41-IT
EUCTR2011-001386-41-IT进行中(未招募)不适用

Role of PET/CT with 124I for dosimetry of thyroid carcinoma before radioisotopic treatment

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2011年12月27日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ?Patients with diagnosis of thyroid carcinoma, already operated by radical tyroidectomy, with lung or bone metastases showing radioiodine uptake; those patients are treated with radiomethabolic therapy using 131I
  • ?age superior or egual to 18years
  • ?male and female
  • ?signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • ?breastfeeding
  • ?patients in emergency situations
  • ?patients of unsound mind

研究者

发起方
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

相似试验

Role of PET/CT with 124I for dosimetry of thyroid... | 临床试验